Aeliya (@aeliyaz) 's Twitter Profile
Aeliya

@aeliyaz

Surgical Reg; PhD-ing, Kidney Transplant. IRI. Hyaluronan (HA), Matrix,Family is everything ❤️,very straightforward. Pakistan ZINDABAD❤️

ID: 1301941819

calendar_today26-03-2013 01:39:14

6,6K Tweet

560 Followers

396 Following

The Royal College of Surgeons of England (@rcsnews) 's Twitter Profile Photo

Registration is open for the Women at the Cutting Edge conference on Friday 17 October in Birmingham. Join Women in Surgery to celebrate innovation and technology, leadership and hear from women leading the way in their fields. Book now: ow.ly/U2R150VX6vy

Registration is open for the Women at the Cutting Edge conference on Friday 17 October in Birmingham.  

Join <a href="/WomenSurgeonsUK/">Women in Surgery</a> to celebrate innovation and technology, leadership and hear from women leading the way in their fields.

Book now: ow.ly/U2R150VX6vy
International Society for Hyaluronan Sciences (@ishas_org) 's Twitter Profile Photo

Important announcement that HA2027 will be based in Porto, Portugal 🇵🇹 May 23rd-27th 2027! Not yet finished HA2025 and already looking forward to the next meeting about our favourite polymer

Important announcement that HA2027 will be based in Porto, Portugal 🇵🇹 May 23rd-27th 2027! Not yet finished HA2025 and already looking forward to the next meeting about our favourite polymer
The Royal College of Surgeons of Edinburgh (@rcsed) 's Twitter Profile Photo

Dr Clare McNaught has been elected as the new President of the Royal College of Surgeons of Edinburgh. Dr McNaught will become the College's first ever female President in the College's 520-year history, and will succeed Professor Rowan Parks. Read more: bit.ly/44kf55F

Dr Clare McNaught has been elected as the new President of the Royal College of Surgeons of Edinburgh.
Dr McNaught will become the College's first ever female President in the College's 520-year history, and will succeed Professor Rowan Parks.

Read more: bit.ly/44kf55F
NEJM (@nejm) 's Twitter Profile Photo

Recent meta-analyses showed that metabolic dysfunction–associated fatty liver disease (MAFLD) is associated with an increased risk of new-onset heart failure, atrial fibrillation, chronic kidney disease (CKD), and certain extrahepatic cancers, increasing the risk of each by a

Recent meta-analyses showed that metabolic dysfunction–associated fatty liver disease (MAFLD) is associated with an increased risk of new-onset heart failure, atrial fibrillation, chronic kidney disease (CKD), and certain extrahepatic cancers, increasing the risk of each by a